CD274 and neoplasm: In literature it has been described that in different cancer types [1], especially immunogenic tumors, including non-small cell lung cancer [2], malignant melanoma [3], and ovarian cancer [4], PD-1 can be upregulated on tumor infiltrating lymphocytes (TILs) and PD-L1 on tumor and immune cells.